article thumbnail

How to Use Generative AI and LLMs to Improve Search

TechEmpower

Artificial Intelligence (AI), and particularly Large Language Models (LLMs), have significantly transformed the search engine as we’ve known it. With Generative AI and LLMs, new avenues for improving operational efficiency and user satisfaction are emerging every day.

article thumbnail

Generative AI – The End of Empty Textboxes

TechEmpower

On a different project, we’d just used a Large Language Model (LLM) - in this case OpenAI’s GPT - to provide users with pre-filled text boxes, with content based on choices they’d previously made. This gives Mark more control over the process, without requiring him to write much, and gives the LLM more to work with.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AT&T Ramps Artificial Intelligence Efforts

socalTECH

AT&T --which has been ramping its operations and presence in the tech world in Los Angeles--said today that it is unveiling a new artificial intelligence (AI) platform called Acumos. The new, open-source platform is aimed at enabling programmers and researchers to more easily develop machine learning and AI software.

article thumbnail

53 Questions Developers Should Ask Innovators

TechEmpower

Even when they have talked to multiple developers or development firms, we’re often the first to ask basic questions like “Who are your customers?” ” or “Are you developing for desktop, tablet, mobile, or all three?” The innovator/developer relationship needs to be a conversation.

Develop 520
article thumbnail

Qulab Applies Artificial Intelligence To Drug Design

socalTECH

Los Angeles-based Qulab , a biopharmaceuticals startup developing artifical intelligence software aimed at small molecule drug design, said on Wednesday that it has launched its first product, Quleap. He also attended USC's Viterbi School of Engineering as a Ph.D. READ MORE>>.

article thumbnail

Erasca Raises $64M For Oncology Drug Development Using AI

socalTECH

San Diego-based Erasca , a company which is using artificial intelligence to drive the discovery and development of new oncology drugs to help cure cancer, has raised $64M in a Series A funding, the company said this morning. According to the company, the new funding will to towards. READ MORE>>.

article thumbnail

A Research Team Plans to Merge AI with Human Brain Cells

Tech.Co

Subscribe Research Team Behind DishBrain Win Funding Monash University released a statement last week confirming that it had been awarded a grant worth hundreds of thousands of dollars to continue its research into “growing human brain cells onto silicon chips, with new continual learning capabilities to transform machine learning”.